(KURA) Kura Oncology - Performance -68.7% in 12m
KURA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-72.75%
#108 in Peer-Group
Rel. Strength
4.72%
#7314 in Stock-Universe
Total Return 12m
-68.72%
#162 in Peer-Group
Total Return 5y
-63.76%
#73 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 23.23 USD |
| 52 Week Low | 5.55 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 82.60 |
| Buy/Sell Signal +-5 | 1.49 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: KURA (-68.7%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: KURA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KURA
| Total Return (including Dividends) | KURA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.61% | 3.64% | 4.08% |
| 3 Months | 12.97% | 23.43% | 19.65% |
| 12 Months | -68.72% | -7.41% | 12.88% |
| 5 Years | -63.76% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | KURA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -60.3% | 30.3% | 86.9% |
| 3 Months | -8.1% | 79.4% | 97.2% |
| 12 Months | -96.3% | -87.3% | 46% |
| 5 Years | -59.6% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th32.50 | -9.89% | -10.27% |
| 3 Month | %th33.50 | -8.48% | -5.59% |
| 12 Month | %th19.50 | -66.21% | -72.29% |
| 5 Years | %th63.50 | -54.28% | -83.02% |
FAQs
Does Kura Oncology (KURA) outperform the market?
No,
over the last 12 months KURA made -68.72%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months KURA made 12.97%, while XBI made 23.43%.
Performance Comparison KURA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
KURA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.5% | -10.7% | -21.6% | -82% |
| US NASDAQ 100 | QQQ | 8.7% | -10.7% | -22.9% | -80% |
| German DAX 40 | DAX | 6.3% | -8.5% | -33.6% | -101% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7% | -11.9% | -25.9% | -90% |
| Hongkong Hang Seng | HSI | 9.7% | -9.1% | -41.8% | -106% |
| India NIFTY 50 | INDA | 9.5% | -6.6% | -21% | -67% |
| Brasil Bovespa | EWZ | 14% | -8.5% | -37.6% | -71% |
KURA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.8% | -8.8% | -25.1% | -92% |
| Consumer Discretionary | XLY | 8.5% | -9.1% | -13.9% | -85% |
| Consumer Staples | XLP | 9.8% | -6.5% | -20.7% | -76% |
| Energy | XLE | 6.6% | -11.8% | -15.1% | -71% |
| Financial | XLF | 9.4% | -10.2% | -25.3% | -96% |
| Health Care | XLV | 7.9% | -7.6% | -11.6% | -63% |
| Industrial | XLI | 7.7% | -11.5% | -28.6% | -94% |
| Materials | XLB | 7.5% | -10.9% | -25% | -75% |
| Real Estate | XLRE | 9% | -6% | -21% | -80% |
| Technology | XLK | 8.5% | -13.5% | -25.8% | -78% |
| Utilities | XLU | 7.6% | -9.4% | -23.9% | -91% |
| Aerospace & Defense | XAR | 8.1% | -13.1% | -39.7% | -117% |
| Biotech | XBI | 4.9% | -10.3% | -11.9% | -61% |
| Homebuilder | XHB | 5.2% | -14.9% | -17.2% | -75% |
| Retail | XRT | 8.2% | -9.4% | -16% | -80% |
KURA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.3% | -11.9% | -6.60% | -62% |
| Natural Gas | UNG | 11.8% | 1.6% | 6.8% | -64% |
| Gold | GLD | 8.8% | -6.4% | -36.5% | -108% |
| Silver | SLV | 7.8% | -8.2% | -35.4% | -89% |
| Copper | CPER | -0.5% | -20% | -42.5% | -91% |
KURA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 8.5% | -8.3% | -17.1% | -67% |
| iShares High Yield Corp. Bond | HYG | 8.8% | -7.8% | -18.1% | -78% |